Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-10 4:22 pm | N/A 2034-06-05 | Third Harmonic Bio Inc. | THRD | Soloway Thomas P Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-08 Disposition | 2023-06-08 4:37 pm | N/A N/A | Satsuma Pharmaceuticals Inc. | STSA | Soloway Thomas P Director | 70,000 | $0 | 0 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:19 pm | N/A 2033-06-05 | Third Harmonic Bio Inc. | THRD | Soloway Thomas P Director | 16,250 | $0 | 16,250 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 5:06 pm | N/A 2032-07-27 | Third Harmonic Bio Inc. | THRD | Soloway Thomas P Director | 90,249 | $0 | 90,249 (Direct) | View |
| 2023-03-06 Disposition | 2023-03-08 5:06 pm | N/A 2032-07-27 | Third Harmonic Bio Inc. | THRD | Soloway Thomas P Director | 90,249 | $0 | 90,249 (Direct) | View |
| 2022-10-26 Option Award | 2022-10-27 5:07 pm | N/A 2032-10-25 | Third Harmonic Bio Inc. | THRD | Soloway Thomas P Director | 13,667 | $0 | 13,667 (Direct) | View |
Ownership | 2022-09-14 6:16 pm | N/A 2032-07-27 | Third Harmonic Bio Inc. | THRD | Soloway Thomas P Director | 0 | $0 | 76,582 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 5:35 pm | N/A 2032-06-02 | Satsuma Pharmaceuticals Inc. | STSA | Soloway Thomas P Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-12-03 Option Award | 2020-12-07 6:03 pm | N/A 2030-12-03 | Satsuma Pharmaceuticals Inc. | STSA | Soloway Thomas P Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-07-02 Option Award | 2020-07-07 4:45 pm | N/A 2030-07-02 | Satsuma Pharmaceuticals Inc. | STSA | Soloway Thomas P Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:38 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 183,384 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:38 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 223,873 | $0 | 0 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 144,669 | $2.7649 | 260,994 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 6,219 | $15.26 | 260,994 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 150,888 | $0 | 260,994 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 41,321 | $2.7649 | 180,994 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:05 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 41,321 | $0 | 180,994 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 30,139 | $59.37 | 180,994 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:17 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 505 | $59.21 | 21,314 (Direct) | View |